Jm. Stutzmann et al., ELECTROGRAPHIC STUDIES OF THE EFFECTS OF RP-60180, A NOVEL KAPPA-AGONIST, ON THE PHOTOSENSITIVE BABOON PAPIO-PAPIO, Progress in neuro-psychopharmacology & biological psychiatry, 19(4), 1995, pp. 687-697
1. The authors describe here the effects of intravenous administration
of RP 60180, a novel kappa agonist, on conscious baboons of the speci
es Papio papio, which spontaneously present photically induced epilept
ic responses. 2. Animals (n=2) were chronically implanted with epidura
l recording electrodes and tested whilst seated in a primate chair. Th
e electrocorticogram (ECoG) and electrocardiogram (EGG) were recorded
during a control period of at least 30 minutes before the injection of
RP 60180 (1 to 4.5 mg/kg i.v.) and immediately afterwards. 3. Qualita
tively, up to the dose of 4.5 mg/kg i.v., RP60180 did not modify ECoG
backgroundin term of paroxysmal activity in comparison with that obser
ved during the control period. It did not cause any manifest focal or
generalized seizure discharges, nor did it consistently enhance or red
uce photically induced myoclonic responses. 4. From the dose of 1 mg/k
g i.v., RP 60180 slowed ECG frequency. This effect, which lasted for a
bout 30 minutes post-injection, was most often seen at the higher dose
s. 5. In another set of experiments, one baboon received the kappa ago
nist U-50488 (a benzacetamide derivative of spiradoline) at 1 and 3 mg
/kg i.v. U-50488, at 3 and to a lesser degree at 1 mg/kg i.v., induced
paroxysmal bursts of slow wave ECoG activity and a slowing of the EGG
. These effects lasted about 1 hour post-drug administration. During t
his period, we observed spontaneous vocalization, as if the animal wer
e complaining, as well as shaking.